Raia Drogasil S.A.
RADLY
$3.62
-$0.07-1.90%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.05% | 8.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.05% | 8.34% | |||
| Cost of Revenue | -13.45% | 8.31% | |||
| Gross Profit | -1.92% | 8.41% | |||
| SG&A Expenses | 0.37% | 10.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.27% | 8.73% | |||
| Operating Income | -37.14% | 2.78% | |||
| Income Before Tax | -56.92% | -43.86% | |||
| Income Tax Expenses | -266.87% | -84.62% | |||
| Earnings from Continuing Operations | -47.79% | -36.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | 288.06% | |||
| Net Income | -46.30% | -32.27% | |||
| EBIT | -37.14% | 2.78% | |||
| EBITDA | -32.87% | 11.38% | |||
| EPS Basic | -49.59% | -26.41% | |||
| Normalized Basic EPS | -67.02% | 0.35% | |||
| EPS Diluted | -50.82% | -26.02% | |||
| Normalized Diluted EPS | -67.96% | 0.71% | |||
| Average Basic Shares Outstanding | 6.40% | -7.84% | |||
| Average Diluted Shares Outstanding | 9.05% | -8.35% | |||
| Dividend Per Share | -- | 110.14% | |||
| Payout Ratio | -1.00% | 6,842.88% | |||